TABRECTA 150 mg/1

TABRECTA 150 mg is a film-coated tablet used for targeted therapy. It contains capmatinib, a medication often discussed in cancer treatment protocols. Learn more about its uses and effects.

TABRECTA 150 mg is primarily used in targeted therapy, often associated with specific cancer treatments. Capmatinib, the active ingredient, is designed to interact with certain proteins in the body. Patients and healthcare providers may explore what is TABRECTA used for in personalized treatment plans.

Common effects of TABRECTA 150 mg may include gastrointestinal discomfort and fatigue. Individual responses can vary, and it's important to monitor any changes while using this medication. Always consult a healthcare provider for personalized advice.

TABRECTA 150 mg should be handled with care, following the guidance of a healthcare professional. It is essential to store the medication properly and adhere to prescribed usage. Pregnant or breastfeeding individuals should discuss potential risks with their doctor.

TABRECTA 150 mg may interact with certain medications, including those metabolized by the liver. Alcohol and other substances can also affect its efficacy. Always inform your healthcare provider about all medications and supplements you are taking.